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Abstract
AIM: To evaluate the relationship between hepato-
cellular carcinoma (HCC) vascularity and grade; to 
describe patterns and vascular/histopathological 
variations of post-transplantation recurrence.
METHODS: This retrospective study included 165 
patients (143 men, 22 women; median age 56.8 years, 
range 28-70.4 years) transplanted for HCC who had a 
follow-up period longer than 2 mo. Pre-transplantation 
dynamic computed tomography or magnetic resonance 
examinations were retrospectively reviewed, classifying 
HCC imaging enhancement pattern into hypervascular 
and hypovascular based on presence of wash-in during 
arterial phase. All pathologic reports of the explanted 
livers were reviewed, collecting data about HCC 
differentiation degree. The association between imaging 
vascular pattern and pathological grade was estimated 
using the Fisher exact test. All follow-up clinical and 
imaging data were reviewed for evidence of recurrence. 
Recurrence rate was calculated and imaging features 
of recurrent tumor were collected, classifying early and 
late recurrences based on timing (< or ≥ 2 years after 
transplantation) and intrahepatic, extrahepatic and both 
intrahepatic and extrahepatic recurrences based on 
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Post-transplantation hepatocellular carcinoma 
recurrence: Patterns and relation between vascularity and 
differentiation degree
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location. All intrahepatic recurrences were classified as 
hypervascular or hypovascular and the differentiation 
degree was collected where available. The presence 
of variations in imaging enhancement pattern and 
pathological grade between the primary tumor and 
the intrahepatic recurrence was evaluated and the 
association between imaging and histopatholgical 
variations was estimated by using the χ 2 test. 
RESULTS: Of the 163 patients with imaging evidence 
of viable tumor, 156 (95.7%) had hypervascular and 
7 (4.3%) hypovascular HCC. Among the 125 patients 
with evidence of viable tumor in the explanted liver, 
19 (15.2%) had grade 1, 56 (44.8%) grade 2, 40 
(32%) grade 3 and 4 (3.2%) grade 4 HCC, while 
the differentiation degree was not assessable for 6 
patients (4.8%). A significant association was found 
between imaging vascularity and pathological grade 
(P  = 0.035). Post-transplantation recurrence rate was 
14.55% (24/165). All recurrences occurred in patients 
who had a hypervascular primary tumor. Three patients 
(12.5%) experienced late recurrence; the location of 
the first recurrence was extrahepatic in 14 patients 
(58.3%), intrahepatic in 7 patients (29.2%) and both 
intrahepatic and extrahepatic in 3 patients (12.5%). 
Two patients had a variation in imaging characteristics 
between the primary HCC (hypervascular) and the 
intrahepatic recurrent HCC (hypovascular), while 1 
patient had a variation of histopathological chara-
cteristics (from moderate to poor differentiation), 
however no association was found between imaging 
and histopathological variations.
CONCLUSION: A correlation was found between 
HCC grade and vascularity; some degree of variability 
may exist between the primary and the recurrence 
imaging/histopathological characteristics, apparently 
not correlated.
Key words: Contrast media; Hepatocellular carcinoma; 
Liver transplantation; Cell differentiation; Recurrence 
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Core tip: During hepatocarcinogenesis, besides the 
differentiation loss, blood supply changes occur. Recently, 
a correlation between higher histopathological grades 
and hypervascular dynamic-imaging enhancement 
pattern has been demonstrated. Hepatocellular carci-
noma recurrence after transplantation is relatively 
common, however the issue of possible variations in 
imaging and histopathology between the primary and 
the recurrent tumor, and particularly the relationship 
between enhancement and grade changes, has never 
been investigated. We demonstrated a correlation 
between vascularity and pathological grade in a large 
population of transplanted patients, and some degree of 
variability between the primary and the recurrent tumor 
vascularity was found, though not associated with 
histopathological changes.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the most frequent 
primary hepatic malignancy[1], and it represents 
an important health issue due to its increasing 
incidence and poor survival[2]. HCC usually arises in 
the background of chronic liver diseases, in particular 
cirrhosis is the substrate of HCC in 80%-90% of 
cases[3]. Carcinogenesis in HCC is typically a multistep 
process, that comprehends low-grade and high 
grade dysplastic nodules possibly with neoplastic 
foci, early HCC, and overt HCC. Pathologically, 
HCC is graded based on differentiation degree into 
four degrees of cellular dysplasia and architectural 
tissue disarrangement (well-differentiated, moder-
ately differentiated, poorly differentiated and un-
differentiated, grade 1 to 4)[4]. During the hepato-
carcinogenesis multistage process, besides the size 
growth and the loss of differentiation of the nodule, 
blood supply changes progressively occur, so that 
the hepatocellular nodule becomes more and more 
dependent on newly formed arteries and in parallel 
less dependent on the portal contribution[3]. 
Contrast-enhanced dynamic imaging, performed 
both with multidetector CT (MDCT) and magnetic 
resonance imaging (MRI), provides information about 
HCC vascularity. In particular, two different hemody-
namic patterns have been featured: the typical, much 
more common, hypervascular pattern, and the less 
frequent hypovascular variant of HCC, which shows 
no arterial phase hypervascularity[5]. Recently, some 
studies have compared contrast enhanced dynamic 
imaging findings with histopathological differentiation 
degree, showing a correlation between higher 
pathological grades and hypervascular enhancement 
pattern[6-10], even though some investigators have 
reported a subsequent decrease in arterial blood supply 
in the late stage of HCC development (grade ≥ 3)[7-9].
Liver transplantation (LT) is the preferred treat-
ment for selected patients with HCC. However, even 
after the introduction of selection criteria such as Milan 
Criteria[11], HCC recurrence rate after LT has been 
estimated to be 8%-17%[12-15]. Many investigators 
have reported on the spectrum of imaging findings 
of HCC recurrence after LT, distinguishing different 
patterns on the basis of recurrence location[12,13,16] 
or timing[14]. In particular, the majority of tumor 
burden in recurrent HCC is typically in extrahepatic 
locations[12,15,16] and the average time to recurrence 
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ranges between 1 and 2 years after LT[14,16]. The 
hemodynamic imaging characteristics of recurred HCC 
have been scarcely reported, however, similarly to the 
primary HCC, the majority of recurred HCC appear as 
hypervascular lesions.
To our knowledge, the issue of possible variations 
in imaging and histopathological characteristics between 
the primary and the recurrent HCC, particularly 
referring to the relationship between enhancement 
pattern changes and differentiation degree changes, 
has never been investigated. The preliminary objective 
of this study was to evaluate the relationship between 
HCC contrast-enhanced dynamic imaging pattern and 
pathological differentiation degree in a population of 
patients transplanted for HCC. Additional aims were 
to describe the patterns and imaging features of HCC 
recurrence after LT and to evaluate the variations in 
imaging and histopathological characteristics between 
the primary HCC and the intrahepatic recurrence, 
particularly elucidating whether differentiation degree 
variations may justify contrast-enhanced imaging 
pattern changes.
MATERIALS AND METHODS
Patients
Between October 2004 and November 2011, a total of 
172 consecutive patients with known HCC underwent 
LT at our hospital. During this period, another patient, 
transplanted without known HCC, had pathologic 
diagnosis of incidental HCC in the liver explant. Of 
these 173 patients, 8 patients were excluded because 
of a short follow up period (≤ 2 mo), as a result of 
perioperative mortality. The remaining 165 patients 
(143 men, 22 women; median age 56.8 years, range 
28-70.4 years), who had a follow-up period longer 
than 2 mo, were included. Fifteen of them were HIV-
infected patients. Clinical data about the etiology of 
the underlying liver disease, were collected. Table 1 
summarizes demographic and clinical characteristics 
of the included patients. 
Pre-transplantation imaging
All available MDCT and MRI dynamic hepatic exami-
nations were reviewed, selecting those with evidence 
of viable tumor, and thus where vascularity was 
assessable. MDCT examinations were performed 
using a 64-slice CT scanner (Lightspeed VCT, GE 
Medical Systems, Milwaukee, Wisconsin, United 
States) with contrast enhancement and bolus-tracking 
technique to obtain a multiphase (arterial, portal 
and hepatic venous phases) examination after an 
unenhanced scan. Image reconstruction was obtained 
with a 2.5 mm slice thickness and a 2.5 mm interval. 
Dynamic MRI studies were conducted on a 1.5-T 
high field magnet (Philips Achieva, Philips Medical 
System, Best, The Netherlands) with a Phased Array 
coil. The protocol included axial T1- and T2-weighted 
sequences with and without fat suppression and 
axial dynamic three-dimensional T1-weighted fat-
suppressed GRE sequences obtained before and after 
a bolus injection of gadopentetate dimeglumine (Gd-
DOTA) in arterial, portal and hepatic venous phases.
Pre-transplantation imaging examinations were 
retrospectively reviewed by two experienced radiolo-
gists by consensus reading, both blinded to the 
results of the pathologic reports. From the last pre-
LT examination with evidence of viable tumor, data 
about the HCC enhancement pattern were collected. 
In particular, based on the presence or absence 
of wash-in, which was defined as present when 
the lesion was hyperattenuating compared to the 
surrounding hepatic parenchyma during the arterial 
phase, lesions were classified into hypervascular and 
hypovascular. 
Histopathology of the explanted liver
A pathologist experienced with liver pathologies 
reviewed all pathologic reports of the explanted 
livers, collecting data about the differentiation 
degree, scored according to the World Health Orga-
nization criteria[4] into well-differentiated (Grade 
1), moderately differentiated (Grade 2), poorly 
differentiated (Grade 3), and undifferentiated (Grade 
4) types. When different degrees were reported in the 
same explanted liver, the prevailing grade (the one 
demonstrated by the larger number of nodules) was 
considered.
Recurrence analysis: Imaging and histopathology
All available postoperative dynamic imaging examin-
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Table 1  Demographic and clinical characteristics of the study population
Demographic and clinical characteristics (n  = 165) 
Sex Male (%)  143 (86.7)
Female (%)    22 (13.3) 
Median age (range) 56.8 (28; 70.4) 
HIV + (%)    15 (9.1) 
Etiology of the underlying 
hepatic disease 
Viral (%) 136 (82.4) HBV-related    28 (17.0) 
HCV-related    92 (55.8) 
Mixed    16 (9.7) 
Not viral (%) 29 (17.6) Alcoholic    16 (9.7) 
Cryptogenetic      6 (3.6) 
Other      7 (4.2) 
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RESULTS
Pre-transplantation imaging and histopathology of the 
explanted liver
Of the 165 patients who were included, 2 had no 
evidence of viable tumor in all dynamic imaging 
examinations performed within 6 mo to LT. Of the 
remaining 163 patients in whom evaluation of 
enhancement pattern was possible, 156 (95.7%) had 
evidence of hypervascular HCC (Table 2). Of these 
163 patients, 125 patients had evidence of viable 
tumor in the explanted liver, while the remaining 38 
patients had completely necrotic nodules as a result of 
pre-transplantation loco-regional therapies performed 
after imaging examinations. The distribution of the 
pathological differentiation degree of the primary 
HCC over the 125 patients who had viable tumor is 
summarized in Table 2. The differentiation degree 
was not assessable for 6 patients (4.8%). Different 
degrees were shown in the same explanted liver in 
5 cases, and in such cases the prevailing grade was 
considered.
Both enhancement pattern and differentiation 
degree were available for 113 patients. Among 
them, a significant association was found between 
imaging enhancement pattern and histopathological 
differentiation degree (P = 0.035). As shown in Table 
3, 50% (3/6) of the patients whit a hypovascular HCC 
had a well-differentiated tumor, vs 14% (15/107) of 
those with a hypervascular HCC. An explicative case 
of a well-differentiated HCC which was characterized 
by an atypical enhancement pattern in the pre-LT 
dynamic MDCT examination is depicted in Figure 1.
Recurrence analysis
Of the 165 patients included, 24 (14.55%) had 
evidence of HCC recurrence after the LT. The 1-, 
3-, 5-years cumulative disease-free survival rates 
according to the Kaplan-Meier method were 92.96%, 
83.9% and 82.84%, respectively. The mean duration 
of recurrence-free survival was 40.15 mo.
Time to development of the recurrence ranged 
from 1.55 to 41.85 mo after LT, with a median value 
of 12.36 mo. Three patients (12.5%) experienced 
late recurrence (≥ 2 years after LT), with a rate of 
1.7% (3/175). All recurrences occurred in patients 
who had a hypervascular primary HCC, while none 
of the patients with hypovascular primary HCC had a 
recurrence after LT.
With respect to recurrence location at the moment 
of the first recurrence, 14 patients (58.3%) showed 
extrahepatic recurrence, 7 patients (29.2%) had 
intrahepatic recurrence and 3 patients (12.5%) 
showed both intrahepatic and extrahepatic recurrence. 
Eight patients had more than one recurrence site 
at the moment of the first recurrence. Only one of 
the 3 patients with late recurrence had intrahepatic 
recurrence. Recurrence patterns and most common 
imaging features of recurrence are further described 
ations (MDCT or MRI) were retrospectively reviewed 
for evidence of recurrent HCC. Proof of recurrence 
was made on the basis of biopsy or growth of 
new lesions with appropriate radiologic features, 
combined with rising AFP levels or with negative 
work-up for another primary malignancy. Imaging 
features of recurrent HCC were collected. Based on 
recurrence timing, recurrences were divided into 
early (< 2 years after LT) and late (≥ 2 years after 
LT). With respect to tumor location at the moment 
of the first recurrence, three different patterns were 
distinguished: intrahepatic recurrence (allograft 
itself), extrahepatic recurrence and both intrahepatic 
and extrahepatic recurrence. 
All follow-up dynamic imaging examinations 
were also reviewed to describe the enhancement 
pattern of all intrahepatic recurrences (those that 
occurred at the moment of the first recurrence and 
subsequent ones), in particular classifying lesions 
into hypervascular and hypovascular based on the 
presence of wash-in. 
Intrahepatic recurrence histopathological differen-
tiation degree was obtained by a review of the 
available pathological reports (in case of biopsy or 
resection of the recurred HCC).
Statistical analysis
The association between pretransplantation HCC enha-
ncement pattern (hypervascular or hypovascular) 
and explanted liver HCC differentiation degree was 
evaluated by using the Fisher exact test. Recurrence 
rate was calculated. The presence of variations in 
imaging features (enhancement pattern) and histopa-
thological characteristics (differentiation degree) 
between the primary and the intrahepatic recurred 
HCC was evaluated and the association between 
imaging and histopatholgical variations was estimated 
by using the χ2 test. For all statistical analyses, a 
P < 0.05 was considered to indicate a statistically 
significant difference.
The statistical methods of this study were re-
viewed by Marta Di Nicola from Department of 
Experimental and Clinical Sciences, Laboratory of 
Biostatistics, University of Chieti, Italy. 
Table 2  Pre-Transplantation imaging enhancement pattern 
and histopathological differentiation degree
Pre-LT imaging and transplant pathology 
Pre-LT imaging 
  Enhancement pattern (n = 163) Hypervascular (%) 156 (95.7) 
Hypovascular (%)     7 (4.3)
Histopathology 
  Differentiation degree (n = 125) Grade 1 (%)   19 (15.2)
Grade 2 (%)   56 (44.8)
Grade 3 (%)   40 (32)
Grade 4 (%)     4 (3.2)
Not assessable (%)     6 (4.8) 
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in Table 4 and some recurrence cases illustrated 
in Figure 2. When extrahepatic recurrences had a 
solid component which was large enough to allow 
vascularity evaluation, they showed a contrast 
enhancement similar to the primary hypervascular 
HCC, hence usually already evident in the arterial 
phase of the examination. Frequently they also 
presented with some necrotic intralesional component.
Among the 14 patients who didn’t show intra-
hepatic recurrence at the moment of the first 
recurrence, 4 had evidence of hepatic recurrence in 
further follow-up imaging examinations. On a total 
of 14 patients who firstly or subsequently developed 
an intrahepatic recurrent HCC, 12 had hypervascular 
and 2 had hypovascular recurrent HCCs, classified 
based on the presence of wash-in. Evidence of wash 
out was shown by all intrahepatic recurrences. Nine 
of them underwent liver biopsy with histological 
diagnosis of HCC, 4 scored as moderately and 5 
scored as poorly-differentiated. Two patients (14.3%) 
showed a variation in imaging characteristics 
between the primary HCC (hypervascular) and the 
intrahepatic recurrent HCC (hypovascular). However, 
they didn’t show any variation in histopathological 
characteristics (Figure 3). Only 1 patient, who 
had hypervascular enhancement pattern on pre-
LT imaging as well as on recurrence imaging, had 
a variation of histopathological characteristics 
(from moderate to poor differentiation) (Figure 4). 
Therefore, no association was found between imaging 
and histopathological variations.
DISCUSSION
It is well known that during HCC development 
progressive changes in the vascular supply occur[3]: as 
dysplastic nodules undergo malignant transformation, 
abnormal neoplastic arterial supply increases while 
portal supply decreases. Classic HCC is exclusively 
supplied by the hepatic artery and lacks a portal 
venous supply, leading, on dynamic imaging 
examinations, to the typical hypervascular pattern 
Table 3  Distribution of dynamic imaging enhancement patterns according to histopathological differentiation degrees
Dynamic imaging enhancement pattern and histopathological differentiation degree (n  = 113)
Enhancement pattern Grade 1 Grade 2 Grade 3 Grade 4 P  value
Hypovascular   3   1   1 1 0.035
Hypervascular 15 52 37 3
Figure 1  Pre-contrast (A), hepatic arterial (B) and hepatic portal venous (C) phases multidetector CT scans demonstrate a hypovascular hepatocellular 
carcinoma (arrows), with no hypervascularization during the arterial phase (wash-in). Pathologically (HE stain, × 100) (D), it was classified as well-differentiated 
(Grade 1).
A B
C D
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characterized by both wash-in in the arterial phase 
and wash-out in portal or delayed phases. Less 
frequently HCCs present as hypovascular lesions, 
enhancing less than the surrounding liver both on 
arterial and venous phase imaging, probably as 
a result of a dual blood supply, both arterial and 
portal[17,18]. 
Some investigators have recently reported a 
correlation between histopathologic grade and HCC 
blood supply in radiological and pathologic analyses. A 
tendency towards higher grades in tumors with hyper-
vascular pattern was demonstrated[6-10], however 
there is some evidence that in the late stage of HCC 
development, the arterial blood supply decreases 
again[7-9]. 
In our population, comparatively with previous 
studies[9], the majority of HCCs were moderately 
or poorly differentiated, almost all of them being 
characterized by a typical hypervascular pattern. 
On the contrary, the few atypical hypovascular 
HCCs were predominantly distributed in the well-
differentiated group, resulting in 50% of patients with 
hypovascular HCC vs only 15% of those with typical 
HCC having a grade 1 tumor. Therefore, despite the 
fact that in our population a very small number of 
patients had evidence of atypical HCC (4.3%), a 
correlation was found between differentiation degree 
and enhancement pattern (P = 0.035).
Recently, some authors have hypothesized the 
utility of imaging pattern as a prognostic factor 
for tumor outcome after locoregional treatment[19] 
or surgery[20,21]. In our study, the pre-LT imaging 
examinations of all the 24 patients who experienced 
HCC recurrence after LT showed hypervascular 
tumors, and all of them were graded as moderately or 
poorly differentiated on histopathology (n = 14 grade 
2, n = 9 grade 3, n = 1 not assessable). No patient 
with hypovascular HCC at pre-LT imaging developed 
Figure 2  Representative multidetector CT images of different recurrence patterns based on the location at the moment of the first recurrence: (A) 
Extrahepatic recurrence presenting with a solitary pleural-based lung nodule; (B) Both intrahepatic and extrahepatic recurrence presenting with bone 
lesions and an intrahepatic lesion in segments IVb and V; (C and D) Intrahepatic recurrence presenting with a solitary hypervascular nodule in segment IV.
A B
C D
Table 4  Recurrence patterns based on the location at the 
moment of the first recurrence and most common imaging 
features of recurrence
Recurrence patterns (n  = 24)
Intrahepatic   7 (29.2%)
Solitary nodule   3 (12.5%)
Multifocal lesions   4 (16.7%)
Extrahepatic 14 (58.3%)
Lung   9 (37.5%)
  Solitary nodule   4 (16.7%)
  Multiple nodules   5 (20.8%)
  Consolidation /
Bone   5 (20.8%)
Osteolytic   5 (20.8%)
Osteoblastic /
Lymph nodes   2 (8.3%)
Brain   1 (4.2%)
Spleen   1 (4.2%)
Adrenal   1 (4.2%) 
Intrahepatic and extrahepatic   3 (12.5%)
Pecchi A et al . Hepatocellular carcinoma recurrence after transplantation
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A
B
Figure 3  Multidetector CT scans demonstrating two 
hypervascular primary hepatocellular carcinoma 
nodules which were graded as moderately differentiated 
on histopathology (HE stain, magnification × 40 
and × 200) (A); Multidetector CT scans of the same 
patient 2 years after LT demonstrating a hypovascular 
intrahepatic recurrent hepatocellular carcinoma, 
which was still graded as moderately differentiated on 
histopathology after resection (HE stain, magnification 
× 40 and × 200) (B). 
A
B
Figure 4  Multidetector CT scans demonstrating a 
hypervascular area representing viable hepatocellular 
carcinoma next to a previously lipiodolized nodule, 
graded as moderately differentiated on histopathology 
(HE stain, magnification × 40 and × 200) (A); 
Multidetector CT scans of the same patients 1 year 
after LT demonstrating a hypervascular intrahepatic 
recurrent hepatocellular carcinoma, which was graded 
as poorly differentiated on histopathology after 
resection (HE stain, magnification × 40 and × 200) (B).
Pecchi A et al . Hepatocellular carcinoma recurrence after transplantation
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post-LT recurrence, not even the few of them with 
a high histopathological degree. These findings 
suggest, albeit the number of cases is limited, a 
lower tendency towards recurrence and a longer 
recurrence-free survival in patients with hypovascular 
rather than hypervascular HCCs, underlying the 
potential prognostic role of vascular supply along with 
the pathological grade. 
In our population the tumor recurrence rate after 
transplantation was 14.55%, which is similar to the 
rates observed in other studies with comparable 
follow-up period and in which Milan selection criteria 
were adopted[12,14,15]. Extrahepatic recurrence was 
the most common recurrence pattern with respect 
to tumor location, comparatively with other studies 
in which the focus was on the appearance of early 
recurrence[12,15,16]. Consistently with previous 
studies[14], the median time to recurrence was 
12.36 mo and late recurrence was less common, 
representing only 12.5% of cases, with a rate of 1.7%.
Focusing on the variations in imaging and histo-
pathological characteristics between the primary and 
the intrahepatic recurred HCC, among the 14 patients 
with intrahepatic recurrence, enhancement pattern 
changes (from hypervascular to hypovascular) were 
experienced by two patients and histopathological 
changes (from moderate to poor differentiation 
degree) were recorded in one patient, underlying 
that some degree of variability may exist between 
the primary and the recurred HCC. Even though the 
number of patients who had changes in imaging or 
pathological characteristics is small, it is to be noted 
that no correlation was found between enhancement 
and differentiation degree changes. In particular, the 
two patients who changed enhancement pattern did 
not show any variation in histopathology between 
the primary and the recurred HCC. On the other 
hand, in one patient a shift from moderately to poorly 
differentiated HCC was observed, while no change in 
the enhancement pattern was registered. This result 
agrees with the higher prevalence of hypervascular 
pattern among both grade 2 and 3 HCCs. 
Some limitations of this study should be noted. 
First, it was designed retrospectively. Second, in the 
correlation analysis between imaging pattern and 
differentiation degree of the primary tumor, wash-out 
was not considered, while recently some studies have 
focused on hypervascular HCCs signal intensity during 
portal venous phase as an additional predictive factor 
for differentiation degree[22]. Finally, this study lacked 
a genomic and immunophenotypical analysis of both 
the primary and the recurrent HCC.
In conclusion, this study confirms the recently 
explored correlation between HCC differentiation 
degree and dynamic-imaging enhancement pattern. 
Moreover, our preliminary results show that some 
degree of variability may exist between the primary 
and the recurred HCC imaging characteristics. If 
tumoral histopathological characteristics do not seem 
to justify enhancement pattern variations, a possible 
explanation is perhaps to be found in changes which 
occur in liver parenchymal structure and vascul-
arity following transplantation[23]. However, more 
studies with larger patient groups are needed to 
better explore the presence of and the reasons for 
enhancement pattern changes between the primary 
and the recurred HCC.
COMMENTS
Background
A correlation between histopathological grade and vascularity of hepatocellular 
carcinoma (HCC) has been recently demonstrated. More frequently HCC is 
hypervascular, an enhancement pattern that usually corresponds to moderate 
or poor differentiation degree. Liver transplantation is the optimal treatment for 
HCC, however recurrence rate still ranges from 8% to 17%. HCC recurrence 
is usually similar to the primary tumor, but some variability in enhancement 
pattern and histopathological characteristics may be expected.
Research frontiers
The relation between HCC pathological grade and vascularity introduces the 
possible role of imaging enhancement pattern as a prognostic factor for tumor 
outcome after transplantation. Moreover, in the field of HCC recurrence after 
transplantation, the reasons for variability between the primary tumor and the 
recurrence characteristics are still to be understood. 
Innovations and breakthroughs
The recently introduced correlation between HCC vascularity and differentiation 
degree has been discussed in other studies, however the authors aimed to 
better explore this relationship by applying it to the issue of HCC recurrence 
after transplantation.
Applications
The most relevant future application of the study is the possible use of 
imaging enhancement pattern as a prognostic factor for tumor recurrence after 
transplantation; moreover the study of recurrence variability may allow to better 
understand the factors involved in post-transplantation recurrence.
Terminology
HCC is the most common type of liver tumor, arising from hepatocytes and 
typically originating in patients with chronic liver diseases; liver transplantation is 
the optimal, potentially curative treatment for HCC; recurrence of hepatocellular 
carcinoma after transplantation reflects hematogenous spread, lymphatic 
spread and peritoneal seeding of neoplastic cells.
Peer review
A very interesting topic, with a somewhat novel approach that justifies thee 
small number of patients included. 
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